Cargando…
Publisher Correction: Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438514/ https://www.ncbi.nlm.nih.gov/pubmed/32814796 http://dx.doi.org/10.1038/s41598-020-71093-9 |
_version_ | 1783572805847089152 |
---|---|
author | Hušáková, Markéta Bay-Jensen, Anne-C. Forejtová, Šárka Zegzulková, Kateřina Tomčík, Michal Gregová, Monika Bubová, Kristýna Hořínková, Jana Gatterová, Jindra Pavelka, Karel Siebuhr, Anne Sofie |
author_facet | Hušáková, Markéta Bay-Jensen, Anne-C. Forejtová, Šárka Zegzulková, Kateřina Tomčík, Michal Gregová, Monika Bubová, Kristýna Hořínková, Jana Gatterová, Jindra Pavelka, Karel Siebuhr, Anne Sofie |
author_sort | Hušáková, Markéta |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7438514 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-74385142020-08-21 Publisher Correction: Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis Hušáková, Markéta Bay-Jensen, Anne-C. Forejtová, Šárka Zegzulková, Kateřina Tomčík, Michal Gregová, Monika Bubová, Kristýna Hořínková, Jana Gatterová, Jindra Pavelka, Karel Siebuhr, Anne Sofie Sci Rep Publisher Correction Nature Publishing Group UK 2020-08-19 /pmc/articles/PMC7438514/ /pubmed/32814796 http://dx.doi.org/10.1038/s41598-020-71093-9 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Publisher Correction Hušáková, Markéta Bay-Jensen, Anne-C. Forejtová, Šárka Zegzulková, Kateřina Tomčík, Michal Gregová, Monika Bubová, Kristýna Hořínková, Jana Gatterová, Jindra Pavelka, Karel Siebuhr, Anne Sofie Publisher Correction: Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis |
title | Publisher Correction: Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis |
title_full | Publisher Correction: Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis |
title_fullStr | Publisher Correction: Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis |
title_full_unstemmed | Publisher Correction: Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis |
title_short | Publisher Correction: Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis |
title_sort | publisher correction: metabolites of type i, ii, iii, and iv collagen may serve as markers of disease activity in axial spondyloarthritis |
topic | Publisher Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438514/ https://www.ncbi.nlm.nih.gov/pubmed/32814796 http://dx.doi.org/10.1038/s41598-020-71093-9 |
work_keys_str_mv | AT husakovamarketa publishercorrectionmetabolitesoftypeiiiiiiandivcollagenmayserveasmarkersofdiseaseactivityinaxialspondyloarthritis AT bayjensenannec publishercorrectionmetabolitesoftypeiiiiiiandivcollagenmayserveasmarkersofdiseaseactivityinaxialspondyloarthritis AT forejtovasarka publishercorrectionmetabolitesoftypeiiiiiiandivcollagenmayserveasmarkersofdiseaseactivityinaxialspondyloarthritis AT zegzulkovakaterina publishercorrectionmetabolitesoftypeiiiiiiandivcollagenmayserveasmarkersofdiseaseactivityinaxialspondyloarthritis AT tomcikmichal publishercorrectionmetabolitesoftypeiiiiiiandivcollagenmayserveasmarkersofdiseaseactivityinaxialspondyloarthritis AT gregovamonika publishercorrectionmetabolitesoftypeiiiiiiandivcollagenmayserveasmarkersofdiseaseactivityinaxialspondyloarthritis AT bubovakristyna publishercorrectionmetabolitesoftypeiiiiiiandivcollagenmayserveasmarkersofdiseaseactivityinaxialspondyloarthritis AT horinkovajana publishercorrectionmetabolitesoftypeiiiiiiandivcollagenmayserveasmarkersofdiseaseactivityinaxialspondyloarthritis AT gatterovajindra publishercorrectionmetabolitesoftypeiiiiiiandivcollagenmayserveasmarkersofdiseaseactivityinaxialspondyloarthritis AT pavelkakarel publishercorrectionmetabolitesoftypeiiiiiiandivcollagenmayserveasmarkersofdiseaseactivityinaxialspondyloarthritis AT siebuhrannesofie publishercorrectionmetabolitesoftypeiiiiiiandivcollagenmayserveasmarkersofdiseaseactivityinaxialspondyloarthritis |